ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Bioscan Research raised $1 million in seed funding. The round supports the company's development of AI-powered biosensors for real-time pathogen detection. The technology aims to improve rapid disease diagnosis and monitoring across healthcare settings.
Tap to vote and see what everyone thinks.
Summary by ByteBrief